Structure-activity of three phospholipid analogues towards inhibition of phospholipase A2 in macrophages

Pharmacological Research

Volumn 35, Issue 1, 1997, Pages 73-78

  Letourneux, Y ^a   Bourass, J ^a   Boucrot, P ^d   Elkihel, L ^a   Petit, J Y ^b,c  

^a Pole Sciences   (France)

^b CEMAGREF   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d NONE

Author keywords

Arachidonic acid; Eicosanoid; Macrophage; Phospholipase A2; Phospholipid analogue

Indexed keywords

1 DECYL 2 OCTYL GLYCEROPHOSPHOCHOLINE; 1 DODECYL 2 OCTANAMIDO 2 DEOXYGLYCEROPHOSPHOCHOLINE; 1 OCTYL 2 OCTYLTHIO 2 DEOXYGLYCEROPHOSPHOCHOLINE; 4 BROMOPHENACYL BROMIDE; CALCIMYCIN; DEXAMETHASONE; ICOSANOID; ICOSATETRAENOIC ACID; LECITHIN 1 OCTADECANOYL 2 [3H] EICOSATETRAENOYLGLYCEROPHOSPHOCHOLINE; MEPACRINE; PHOSPHOLIPASE A2; PHOSPHOLIPID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME INHIBITION; MACROPHAGE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0030940451     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0107     Document Type: Article

References (27)

1. 1. Bonsen PBM, De Haas GH, Pieterson WA, Van Deenen LLM. Studies on phospholipase A and its Zymogen from porcine pancreas, IV. The influence of chemical modification of the lecithin structure on substrate properties. Biochim Biophys Acta 1972; 270: 364-82.
2. 2. Yu L, Deems RA, Hajdu J, Dennis EA. The interaction of phospholipase A2 with phospholipid analogues and inhibitors. J Biol Chem 1990; 267: 2657-64.
3. 2 from pig, ox and horse by comparing the inhibitory power of a number of (R)-2-acylamino phospholipid analogues. Biochim Biophys Acta 1994; 1212: 50-8.
4. 2 des macrophages péritoneaux de rat par la 1,2 dihexadécyl-sn-glycéro-3-phosphocholine. CR Acad Sci Paris 1993; 316: 169-76.
5. 2 mechanism: inhibition and role in arachidonic acid release. Drug Dev Res 1987; 10: 205-20.
6. 6. Baumann WJ, Mangold HK. Reaction of aliphatic methane sulfonate synthesis of long chain di and trialkyl glyceryl ethers. J Org Chem 1966; 31: 498-9.
7. 7. Kohli V, Blocker H, Koster H. The triphenylmethyl (trityl) group and its use in nucleotide chemistry. Tetrahedron Lett 1980; 21: 2683-6.
8. 2 inhibition in macrophages. J Enzyme Inhib 1995; 9: 135-45.
9. 9. Chandrakumar NS, Hajdu J. Synthesis of enzyme inhibitory phospholipid analogs. II. Preparation of chiral 1-acyl 2-acylamido 2-deoxy glycerophosphocholine from serine. Tetrahedron Lett 1981; 22: 2949-52.
10. 2 inhibition. Arch Int Physiol Biochem Biophys 1994; 102: 271-5.
11. 11. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-7.
12. 12. Sugiura T, Masuzawa Y, Waku K. Alkenyl and alkyl ether phospholipids in pigs mesenteric lymph node lymphocytes. Lipids 1980; 15: 475-8.
13. 13. Diagne A, Fauvel J, Record M, Chap H, Douste-Blazy L. Studies on ether phospholipids. II. Comparative composition of various tissues from human, rat and guinea pig. Biochim Biophys Acta 1984; 793: 221-31.
14. 2 from BCG-induced rabbit alveolar macrophages. Biochim Biophys Acta 1981; 658: 54-63.
15. 15. Wightman PD, Dahlgren ME, Davies P, Bonney RJ. The selective release of phospholipase A2 by resident mouse peritoneal macrophages. Biochem J 1981; 200: 441-4.
16. 16. Bonney RJ, Wightman PD, Davies P, Sadowski SJ, Kuehl FA Jr, Humes JL. Regulation of prostaglandin synthesis and of selective release of lysosomal hydrolases by mouse peritoneal macrophages. Biochem J 1978; 176: 433-42.
17. 2 from snake venom, pancreas and a macrophage like cell line. J Biol Chem 1990; 265: 5602-9.
18. 18. Mahadevappa VG, Powel W. The metabolism of arachidonic and eicosapentaenoic acids in human neutrophils stimulated by A23187 and FMLP. J Cell Biochem 1989; 40: 341-52.
19. 19. Tokumara A, Tsutsumi T, Yoshida J, Tsukatani H. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkyl acylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes. Biochim Biophys Acta 1990; 1044: 91-100.
20. 20. Schmidt B, Flesh B, Hovestadt I, Ferber R. Membrane phospholipid changes during macrophage activation. Agent and Actions 1984; 15: 21-7.
21. 13C NMR and phospholipase studies. Biochemistry 1981; 20: 5945-50.
22. 22. Huang CH, Lapides JR, Levin IW. Phase-transition behavior of saturated symmetric chain phospholipid bilayer dispersions determined by Raman spectroscopy. Correlation between spectra and thermodynamic parameters. J Am Chem Soc 1982; 104: 5926-30.
23. 23. Blackwell GJ, Flower RJ. Inhibition of phospholipases. British Med Bull 1983; 39: 260-4.
24. 2 function and pharmacological regulation. Biochem Pharmacol 1987; 36: 2429-36.
25. 2 enzymes: regulation and inhibition. Trends Pharmacol Rev 1993; 141: 92-8.
26. 26. Barnes PJ, Adcock L. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Rev 1993; 141: 436-9.
27. 2 in mouse macrophages and suppresses its activation. Biochem J 1995; 307: 499-504.